Loading…
The effect of transdermal 17- β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration
Objectives: To evaluate the effect of transdermal 17- β-estradiol (50 μg/day) on glucose metabolism of postmenopausal women. Study design: A frequently sampled intravenous glucose tolerance test (FSIGT), to calculate insulin sensitivity ( S I) and peripheral glucose utilization independent of insuli...
Saved in:
Published in: | Maturitas 1997-12, Vol.28 (2), p.163-167 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives: To evaluate the effect of transdermal 17-
β-estradiol (50
μg/day) on glucose metabolism of postmenopausal women.
Study design: A frequently sampled intravenous glucose tolerance test (FSIGT), to calculate insulin sensitivity (
S
I) and peripheral glucose utilization independent of insulin (
S
G), and an oral glucose tolerance test (75 g; OGTT), were performed in nine postmenopausal women prior to, and after 2 months of, treatment.
Results: Estradiol decreased insulin and increased the C-peptide/insulin ratio both during fasting (
P |
---|---|
ISSN: | 0378-5122 1873-4111 |
DOI: | 10.1016/S0378-5122(97)00064-9 |